A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20 mg Compared to Lansoprazole 30 mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Duodenal Ulcer Subjects With or Without Helicobacter Pylori Infection

Name: A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20 mg Compared to Lansoprazole 30 mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Duodenal Ulcer Subjects With or Without Helicobacter Pylori Infection
Creator: Vivli
Published: 2025-10-01 20:54:27
License: 暂无描述

DataCite Commons2025-10-01 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/00007238/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to demonstrate the non-inferior efficacy of TAK-438 versus lansoprazole in the treatment of participants with duodenal ulcer.

提供机构：

Vivli

创建时间：

2021-06-25